HRV and Blood Work: Connecting the Dots
Table of Contents
Introduction
Most athletes monitoring their health are doing it in silos. They review a blood panel once or twice a year, note a ferritin or vitamin D level, and file the report away. Separately, they glance at a morning HRV score on their wearable, unsure what to do when the number dips. What they’re missing is the connection between HRV and blood work.
HRV and blood biomarkers don’t exist in isolation. They’re reading from the same underlying physiological system — and learning to interpret them together gives athletes a substantially richer picture of what’s actually happening in the body.
At present, biometric monitoring tools and the data they generate remain poorly integrated into clinical practice. This is partly due to a lack of standardisation across devices and platforms, but also reflects the rapid pace at which these technologies have evolved — often faster than healthcare systems and practitioners can fully adapt.
In clinical practice, this gap is increasingly visible. Many of my patients now track metrics such as HRV regularly using consumer wearables, including smart rings and watches, yet this data is rarely incorporated in a structured or clinically meaningful way into their care.
What HRV Actually Measures
HRV refers to the variation in time between consecutive heartbeats. A healthy heart doesn’t beat with robotic regularity — it fluctuates in response to the constant interplay between the sympathetic (“fight or flight”) and parasympathetic (“rest and digest”) branches of the autonomic nervous system (ANS). Higher resting HRV is generally interpreted as reflecting greater parasympathetic influence in healthy individuals, associated with better recovery and readiness. Lower HRV signals heightened sympathetic activity, elevated stress load, or impaired recovery [1].
Among the various HRV metrics, RMSSD (root mean square of successive differences) has emerged as the most practical for day-to-day athlete monitoring due to its strong association with parasympathetic activity and its stability across short measurement windows [1]. Daily HRV values are most meaningfully interpreted as a rolling weekly average rather than isolated single-day readings, since transient factors — poor sleep, caffeine, or emotional stress — can distort any individual measurement [1].
HRV, particularly RMSSD tracked over time, is a widely used and supported adjunct marker for monitoring recovery and training adaptation, though its interpretation varies by sport context and should not be used in isolation [2].
In my practice, many patients now bring up their HRV data during consultations. I see this particularly often in individuals experiencing fatigue or burnout, where HRV is often lower than their usual baseline. Similar patterns are also common during acute infections, frequently alongside an elevated resting heart rate.
These changes understandably raise concern. Patients often ask what the findings mean, whether something is wrong, and how the situation should be evaluated further — including whether laboratory testing is needed.
HRV and Blood Work: Why They Should Be Interpreted Together
HRV captures the output of the ANS — but it cannot tell you why that output has changed. A persistently suppressed HRV might reflect inadequate sleep, excessive training volume, or psychological stress. It might equally reflect a micronutrient deficiency, a subclinical hormonal disruption, or chronic low-grade inflammation. Blood biomarkers provide the mechanistic context that HRV alone cannot.
Many of the following tests are already familiar to patients, particularly those who actively monitor their health or follow performance and recovery metrics. In my practice, I often see patients reference these markers in the context of their own data and symptoms. Some of these are tests we actively use in my clinic as part of routine evaluation, while others remain more exploratory and are currently used primarily in research settings.
Iron and Ferritin
Iron is essential for oxygen transport and mitochondrial function. When iron stores are insufficient — even before anemia develops — cellular oxygen delivery is impaired, cardiac output must compensate, and autonomic regulation becomes strained.
Research in female populations has identified a recurring pattern across several studies: women with iron deficiency anemia show significant reductions in parasympathetic HRV indicators (SDNN and RMSSD) and elevated sympathetic markers including increased LF power and LF/HF ratio compared to controls, with ferritin levels showing a significant negative correlation with sympathetic indices — as ferritin falls, sympathetic tone rises [3].
It is important to note that this evidence specifically examines frank iron deficiency anemia rather than the pre-anemic iron depletion that is common among athletes. That said, sports medicine research supports the use of higher ferritin thresholds in athletic populations. Studies in female athletes have used ferritin levels below approximately 40 µg/L to define iron deficiency — substantially higher than the WHO general population cut-off of 15 µg/L [4]. An athlete sitting at a ferritin of 22–28 µg/L may be technically within a standard reference range while already experiencing fatigue and impaired training tolerance, making a declining HRV trend a useful contextual signal worth investigating — although direct HRV evidence at these low-normal ferritin levels remains limited [3][4]. For a more detailed discussion on optimal ferritin levels in athletes see my guide.
In my practice, iron deficiency is relatively common among athletes. In many cases, haemoglobin levels remain within the normal range, and athletes are often unaware that optimal ferritin targets for performance are higher than general population reference ranges.
In these situations, I typically recommend iron supplementation alongside dietary strategies, with an emphasis on increasing intake of heme iron sources. This can be more challenging in athletes who follow vegetarian or restrictive diets, as well as those competing in weight-class sports, where nutritional intake is often constrained.
Vitamin D
Vitamin D receptors are expressed throughout the cardiac and nervous systems, and deficiency appears to impair both cardiac autonomic tone and parasympathetic activity. Studies in apparently healthy individuals with vitamin D deficiency have found significantly reduced RMSSD, SDNN, pNN50, and HF power compared to vitamin D–sufficient controls, alongside increased LF power and LF/HF ratio, indicating a shift toward sympathetic dominance [5]. Serum 25(OH)D levels correlated positively with every major parasympathetic HRV parameter, with these differences present despite the absence of overt cardiac symptoms [5].
A review of micronutrient-HRV research across human populations confirmed that accumulating evidence links vitamin D deficiency with reduced HRV, with an interventional study demonstrating that vitamin D3 supplementation improved several HRV indices consistent with enhanced parasympathetic activity in adults with vitamin D insufficiency [6]. The evidence remains promising but should be interpreted with the caveat that most intervention studies have been small and of limited duration.
For athletes at elevated risk of deficiency — due to indoor training environments, high-latitude residence, or limited sun exposure — a seasonal decline in HRV over winter months should prompt consideration of 25(OH)D testing, particularly in those with additional risk factors. For a more detailed breakdown of optimal levels, supplementation strategies, and performance implications, see my guide on vitamin D for athletes.
In Finland, my home country, vitamin D deficiency is common in both athletes and the general population due to limited sunlight exposure, particularly during the winter months. At this latitude, cutaneous vitamin D synthesis is minimal for a significant part of the year, making deficiency more likely without adequate dietary intake or supplementation. Even though vitamin D is widely discussed both in clinical practice and in the media, intake often remains insufficient. In Finland, the current nutritional recommendation is 10 µg per day [10], which may be inadequate for many of my patients — particularly athletes and those at higher risk of deficiency.
Cortisol and Hormonal Stress Markers
Persistent training overload disrupts both the hypothalamic-pituitary-adrenal (HPA) and hypothalamic-pituitary-gonadal (HPG) axes. A systematic review of 38 studies on hormonal aspects of overtraining syndrome found that basal hormone levels were mostly within normal ranges in overtrained athletes — resting cortisol was normal in 75% of study findings, and resting testosterone was normal in 66.7% — though the testosterone-to-cortisol (T/C) ratio showed reduced values in approximately 50% of studies where it was measured [7]. Catabolic hormones including cortisol tended toward elevation at resting baseline, while anabolic hormone findings showed conflicting results across studies [7].
This reflects an important clinical nuance: single-point resting hormone measurements are not reliable markers of overtraining. The T/C ratio is more informative as a trend measure, reflecting the anabolic-catabolic balance and the actual degree of physiological strain in training rather than confirming the presence of overtraining syndrome per se [8].
In practice, HRV provides the real-time trend signal — consistently suppressed morning values across two or more weeks — while a targeted hormonal panel adds useful context when clinical overreaching is suspected. The combination is more informative than either marker alone.
In routine clinical practice, however, cortisol is rarely measured outside of specific endocrine evaluations. In Finland, in particular, it has little role in general clinical work, especially given that baseline levels are often within the normal range even in the context of fatigue or suspected overreaching.
Testosterone, on the other hand, is measured more frequently in male patients, but typically as part of a broader evaluation — most often in the context of fatigue or reduced libido. It is rarely assessed specifically as a marker of overtraining in routine clinical practice.
The T/C ratio, while commonly discussed in sports science literature, is not something that is routinely measured in day-to-day clinical work. It remains largely a research-oriented metric. In practice, changes in the ratio are often driven primarily by fluctuations in testosterone, meaning that testosterone alone captures part of the same signal — although it is not a particularly sensitive marker of training stress on its own.
Inflammation: CRP and IL-6
HRV’s relationship with inflammation is one of its most clinically important and underutilised dimensions. Research consistently demonstrates an inverse association between HRV and pro-inflammatory markers: lower HRV is associated with higher concentrations of CRP and IL-6 [9]. This relationship is mediated in part by the vagal anti-inflammatory pathway — the parasympathetic nervous system, via the vagus nerve, exerts a suppressive effect on cytokine release. When vagal tone falls, as reflected in reduced HRV, inflammatory activity is less effectively modulated [9].
A meta-analysis of 51 studies involving 2,238 participants confirmed inverse associations between HRV indices and a broad panel of inflammatory markers including IL-6, IL-1, TNF, white blood cell count, fibrinogen, and CRP [9]. These findings come largely from cross-sectional and cardiovascular research populations, but the underlying mechanism — vagal modulation of immune activity — is relevant to athletes undergoing high training loads. When HRV remains suppressed following a hard training block, elevated CRP on a concurrent blood panel can support a clinical judgement to prioritise recovery rather than continued loading, though this represents an applied extrapolation rather than a directly tested athlete management protocol.
In my practice, many patients with inflammatory conditions — particularly during acute infections — show a clear reduction in HRV. Their consumer wearables, such as smartwatches and rings, often reflect this as poor recovery and, in many cases, reduced sleep quality.
Summary
HRV and blood biomarkers should not be viewed as separate tools, but as complementary signals reflecting the same underlying physiology. HRV provides a continuous, real-time window into autonomic balance, recovery status, and overall stress load, while blood tests offer the biological context needed to understand why those changes are occurring. When interpreted together, they allow for a more nuanced and clinically meaningful picture than either measure alone.
In practice, a persistently suppressed HRV is rarely explained by a single factor. It may reflect training load, poor sleep, psychological stress, or illness — but it can also signal underlying issues such as low iron stores, vitamin D deficiency, hormonal imbalance, or low-grade inflammation. Blood biomarkers help identify these drivers, while HRV helps track how the body responds over time, often providing early feedback before changes are visible in repeat laboratory testing.
From a clinical perspective, this integrated approach is particularly valuable in athletes and physically active individuals, where subtle changes in physiology can have a meaningful impact on performance and recovery. It also reflects the reality of modern practice, where patients increasingly arrive with their own longitudinal data from wearables. Rather than dismissing this information, clinicians can use it as a starting point — combining subjective symptoms, HRV trends, and targeted laboratory evaluation to guide decision-making.
Ultimately, the goal is not to replace clinical judgement with data, but to enhance it. HRV can highlight when something is changing; blood work can help explain what and why. Together, they support a more proactive, individualised, and physiologically grounded approach to health, recovery, and performance.
References
- https://www.mdpi.com/1424-8220/26/1/3
- https://pmc.ncbi.nlm.nih.gov/articles/PMC11204851/
- https://academicmed.org/Uploads/Volume6Issue4/175.%20%5B3758.%20JAMP_Nirmaladevi%20S%5D%20896-903.pdf
- https://pubmed.ncbi.nlm.nih.gov/33132346/
- https://pubmed.ncbi.nlm.nih.gov/25363566/
- https://pmc.ncbi.nlm.nih.gov/articles/PMC7231600/
- https://pmc.ncbi.nlm.nih.gov/articles/PMC5541747/
- https://pubmed.ncbi.nlm.nih.gov/8584849/
- https://pmc.ncbi.nlm.nih.gov/articles/PMC4476948/
- https://www.ruokavirasto.fi/elintarvikkeet/terveytta-edistava-ruokavalio/ravintoaineet/d-vitamiini/
